Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Deficit)

v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2022   37,442,663      
Beginning Balance at Dec. 31, 2022 $ 1,466 $ 4 $ 127,693 $ (125,791) $ (440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   112,252      
Exercise of common stock options 85   85    
Share-based compensation expense 533   533    
Foreign currency translation adjustment (33)       (33)
Net loss (5,239)     (5,239)  
Ending Balance (in shares) at Mar. 31, 2023   37,554,915      
Ending Balance at Mar. 31, 2023 (3,188) $ 4 128,311 (131,030) (473)
Beginning Balance (in shares) at Dec. 31, 2022   37,442,663      
Beginning Balance at Dec. 31, 2022 1,466 $ 4 127,693 (125,791) (440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (10,272)        
Ending Balance (in shares) at Jun. 30, 2023   40,800,078      
Ending Balance at Jun. 30, 2023 3,989 $ 4 140,819 (136,063) (771)
Beginning Balance (in shares) at Mar. 31, 2023   37,554,915      
Beginning Balance at Mar. 31, 2023 (3,188) $ 4 128,311 (131,030) (473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock and warrants, net of issuance costs (in shares)   3,125,000      
Issuance of common stock and warrants, net of issuance costs 11,845   11,845    
Exercise of common stock options (in shares)   82,121      
Exercise of common stock options 93   93    
Exercise of common stock warrants (in shares)   38,042      
Share-based compensation expense 570   570    
Foreign currency translation adjustment (298)       (298)
Net loss (5,033)     (5,033)  
Ending Balance (in shares) at Jun. 30, 2023   40,800,078      
Ending Balance at Jun. 30, 2023 $ 3,989 $ 4 140,819 (136,063) (771)
Beginning Balance (in shares) at Dec. 31, 2023 48,613,714 48,613,714      
Beginning Balance at Dec. 31, 2023 $ 23,321 $ 5 169,197 (144,962) (919)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   62,535      
Exercise of common stock options 59   59    
Exercise of common stock warrants (in shares)   94,804      
Share-based compensation expense 885   885    
Foreign currency translation adjustment 13       13
Net loss (6,499)     (6,499)  
Ending Balance (in shares) at Mar. 31, 2024   48,771,053      
Ending Balance at Mar. 31, 2024 $ 17,779 $ 5 170,141 (151,461) (906)
Beginning Balance (in shares) at Dec. 31, 2023 48,613,714 48,613,714      
Beginning Balance at Dec. 31, 2023 $ 23,321 $ 5 169,197 (144,962) (919)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (14,949)        
Ending Balance (in shares) at Jun. 30, 2024 49,080,486 49,080,486      
Ending Balance at Jun. 30, 2024 $ 10,474 $ 5 171,480 (159,911) (1,100)
Beginning Balance (in shares) at Mar. 31, 2024   48,771,053      
Beginning Balance at Mar. 31, 2024 17,779 $ 5 170,141 (151,461) (906)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   210,533      
Exercise of common stock options 154   154    
Issuance of common stock for settlement of restricted stock units and stock awards (in shares)   98,900      
Share-based compensation expense 1,152   1,152    
Change in fair value of the warrant 33   33    
Foreign currency translation adjustment (194)       (194)
Net loss $ (8,450)     (8,450)  
Ending Balance (in shares) at Jun. 30, 2024 49,080,486 49,080,486      
Ending Balance at Jun. 30, 2024 $ 10,474 $ 5 $ 171,480 $ (159,911) $ (1,100)